Artificial intelligence (AI) is the future of clinical data management with the potential to aid in the intersection between complex data and clinical decision making. Given AIs ability to rapidly analyze big data, interventional radiologists (IR) can design more individualized staging systems by… Read More
Reviewing Studies
At the time of percutaneous transhepatic portal vein embolization (PVE), hyperbilirubinemia has no apparent effect on future liver remnant (FLR) hypertrophy, according to a study published in the Journal of Vascular and Interventional Radiology. Grade 3 post-hepatectomy liver failure incidence was… Read More
Transcatheter arterial chemoembolization (TACE) combined with apatinib (TACE-apatinib) prolonged time to progression (TTP) and overall survival (OS) compared to TACE-alone for Barcelona Clinic Liver Cancer (BCLC) stage C HCC, according to a study published in BMC Cancer. This retrospective study… Read More
HCC liver
Long-term survival in patients with massive hepatocellular carcinomas (MHCC) was improved when treatment consisted of transcatheter arterial chemoembolization (TACE) combined with percutaneous microwave coagulation therapy (PMCT) compared with TACE alone, according to a study publishes in Cancer… Read More
HCC cells
No significant difference in overall survival (OS) and liver cancer-specific survival (LCSS) was found in patients with localized hepatocellular carcinoma (HCC) treated with either cryoablation (cryo) or radiofrequency ablation (RFA), according to a study published in Anticancer Research. This… Read More
IV drips
Transarterial radioembolization with yttrium-90 (TARE-Y90) of unresectable primary liver malignancy demonstrates an anticancer effect and could be used as adjunctive therapy in pediatric patients with unresectable hepatic malignancies. A new study published in Pediatric Blood & Cancer found… Read More
medical studies
Endovascular denervation (EDN) can improve pain in patients with abdominal cancer and may offer a new approach to palliative care, according to a study published in the Journal of Vascular and Interventional Radiology. The study enrolled 7 patients with diagnoses including pancreatic cancer (n =… Read More
HCC cells
The potential value of α-fetoprotein (AFP) classification in clinical practice is demonstrated according to a study published in the Journal of Vascular and Interventional Radiology. The results showed that AFP categories agreed moderately with modified Response Evaluation Criteria In Solid Tumors… Read More
Reviewing Studies
A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) (TriSalus Life Sciences’) is safe, with encouraging clinical responses, according to the results of a phase 1b clinical trial presented in a poster at the Society… Read More
HCC cells
In patients with ultrasound (US)-invisible early stage hepatocellular carcinoma (HCC), the combined therapy of conventional transarterial chemoembolization (cTACE) followed by fluoroscopy-guided radiofrequency ablation (RFA) was safe and effective resulting in less local tumor progression (LTP) and… Read More